General Catalyst’s Customer Value Fund (CVF) provides late-stage companies with a balance sheet for growth. CVF pre-funds companies’ sales and marketing and is paid back by a capped share of the ...

The RSUs will vest over four years, with 25% of the shares vesting on the first anniversary of the applicable vesting commencement date, and the balance vesting annually thereafter in three equal ...

Annovis Bio, Inc. (NYSE: ANVS) ("Annovis" or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases such as Alzheimer's disease ...

Vitalhub Corp. (TSX: VHI) (OTCQX: VHIBF) (the “Company” or “VitalHub”) announced that it has completed the cash acquisition of Induction Healthcare Group PLC (“Induction”) by way of a court-sanctioned ...

Nusano will supply dGenThera with At-211 in quantities sufficient to enable the company’s ongoing preclinical studies, first‑in‑human trials, and subsequent clinical development. The agreement ...